Overall rank by patents
#855
of 49,997 tracked assignees
USPTO PatentsView assignee record - 533 granted patents across 55 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).
The verdict
According to USPTO PatentsView, Medtronic ranks #855 of 49,997 tracked US assignees by granted-patent volume, with 533 patents across 55 technology areas.
USPTO PatentsView assignee plate
Corpus R855 · US Corporation #855 · 533 grants
GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL
Nearest grant-volume peer: NuFlare Technology, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
E Ink Holdings · near
63 score
Hayward Industries · near
63 score
Smith & Nephew · near
63 score
Spotify AB · near
63 score
Medtronic Vascular · this assignee
63 score
3D Lighting… · lowest
7 score
What this shows Medtronic's Innovation Score is 63.0/100 (top 2% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Between 2020–2024, Medtronic Vascular, Inc. received 277 grants versus 227 in 2015–2019 (+22% equal-window velocity, above median growth). Across complete PatentsView years, output peaked in 2020 at 65 grants and bottomed in 2017 at 34. Lead class A61F accounts for 71.9% of the portfolio across 55 subclasses. Volume neighbours: Technion Research & Development Foundation Limited (#851) and Arthrex, Inc. (#859).
From 2019–2021 to 2022–2024, Medtronic Vascular, Inc. moved from 174 to 166 grants (0.95x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,310. See the growth leaderboard.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Technion Research & Development Foundation Limited
537 patents
Medos International Sarl
535 patents
Veritas Technologies LLC
535 patents
Kyndryl, Inc.
534 patents
NuFlare Technology, Inc.
533 patents
Medtronic Vascular, Inc.
533 patents
Micro Focus LLC
532 patents
Waters Technologies Corporation
531 patents
Arthrex, Inc.
526 patents
What this shows Medtronic holds 533 patents at rank #855, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #855 in granted patent volume.
Other assignees with the most granted patents in Medtronic's primary technology class.
Two PlainPatent-derived peer sets for Medtronic, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (63 here).
Nearest assignees by average claims per patent (16.6 here).
Medtronic's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
63 Top 2% higher than 98% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 42 | 7.9% |
| 2016 | 47 | 8.8% |
| 2017 | 34 | 6.4% |
| 2018 | 41 | 7.7% |
| 2019 | 63 | 11.8% |
| 2020 | 65 | 12.2% |
| 2021 | 46 | 8.6% |
| 2022 | 56 | 10.5% |
| 2023 | 61 | 11.4% |
| 2024 | 49 | 9.2% |
| 2025partial year | 29 | 5.4% |
Top 15 of 55 technology areas
Overall rank by patents
#855
of 49,997 tracked assignees
63.0 out of 100
What to do with this data
Medtronic Vascular, Inc.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.